← Open Payments lookup

SYDNEY SHIVERS: Open Payments

NPI 1053017616 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,415 in 48 payments from 11 companies in 2025. Trend: 2023 $696 · 2024 $631 · 2025 $1,415

Food & beverage: $1,415
CompanyPaymentsAmount
ABBVIE INC.27$820
Gilead Sciences, Inc.4$175
Ipsen Biopharmaceuticals, Inc4$120
Janssen Biotech, Inc.3$69
Aimmune Therapeutics, Inc.3$54
QOL Medical, LLC1$40
GENZYME CORPORATION1$39
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$30
Fresenius Kabi USA, LLC1$27
Ardelyx, Inc.1$23

Products named: RINVOQ, SKYRIZI, LINZESS, IQIRVO, TREMFYA, ZENPEP, CREON, Sucraid.

Industry payments across TX — which companies pay providers there.